- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Gastrointestinal Stromal Tumor (GIST) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Gastrointestinal Stromal Tumor (GIST) Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Gastrointestinal Stromal Tumor (GIST) Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Gastrointestinal Stromal Tumor (GIST) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Market segment by Application can be divided into
Clinic
Hospital
Others
The key market players for global Gastrointestinal Stromal Tumor (GIST) Drug market are listed below:
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor (GIST) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug, with price, sales, revenue and global market share of Gastrointestinal Stromal Tumor (GIST) Drug from 2019 to 2021.
Chapter 3, the Gastrointestinal Stromal Tumor (GIST) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastrointestinal Stromal Tumor (GIST) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Gastrointestinal Stromal Tumor (GIST) Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Gastrointestinal Stromal Tumor (GIST) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size & Forecast
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value (2016-2026))
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume (2016-2026)
1.4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity Analysis
1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Total Production Capacity (2016-2026)
1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
1.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
1.6.3 Gastrointestinal Stromal Tumor (GIST) Drug Trends Analysis
2 Manufacturers Profiles
2.1 Ariad Pharmaceuticals, Inc.
2.1.1 Ariad Pharmaceuticals, Inc. Details
2.1.2 Ariad Pharmaceuticals, Inc. Major Business
2.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Arog Pharmaceuticals, Inc.
2.2.1 Arog Pharmaceuticals, Inc. Details
2.2.2 Arog Pharmaceuticals, Inc. Major Business
2.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Array BioPharma Inc.
2.3.1 Array BioPharma Inc. Details
2.3.2 Array BioPharma Inc. Major Business
2.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Astex Pharmaceuticals, Inc.
2.4.1 Astex Pharmaceuticals, Inc. Details
2.4.2 Astex Pharmaceuticals, Inc. Major Business
2.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Blueprint Medicines Corporation
2.5.1 Blueprint Medicines Corporation Details
2.5.2 Blueprint Medicines Corporation Major Business
2.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Boston Biomedical, Inc.
2.6.1 Boston Biomedical, Inc. Details
2.6.2 Boston Biomedical, Inc. Major Business
2.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Calithera Biosciences, Inc.
2.7.1 Calithera Biosciences, Inc. Details
2.7.2 Calithera Biosciences, Inc. Major Business
2.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Chipscreen Biosciences Ltd
2.8.1 Chipscreen Biosciences Ltd Details
2.8.2 Chipscreen Biosciences Ltd Major Business
2.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Deciphera Pharmaceuticals, LLC
2.9.1 Deciphera Pharmaceuticals, LLC Details
2.9.2 Deciphera Pharmaceuticals, LLC Major Business
2.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 F. Hoffmann-La Roche Ltd.
2.10.1 F. Hoffmann-La Roche Ltd. Details
2.10.2 F. Hoffmann-La Roche Ltd. Major Business
2.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Horizon Pharma Plc
2.11.1 Horizon Pharma Plc Details
2.11.2 Horizon Pharma Plc Major Business
2.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Immunicum AB
2.12.1 Immunicum AB Details
2.12.2 Immunicum AB Major Business
2.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Jiangsu Hengrui Medicine Co., Ltd.
2.13.1 Jiangsu Hengrui Medicine Co., Ltd. Details
2.13.2 Jiangsu Hengrui Medicine Co., Ltd. Major Business
2.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Kolltan Pharmaceuticals, Inc.
2.14.1 Kolltan Pharmaceuticals, Inc. Details
2.14.2 Kolltan Pharmaceuticals, Inc. Major Business
2.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Natco Pharma Limited
2.15.1 Natco Pharma Limited Details
2.15.2 Natco Pharma Limited Major Business
2.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Nerviano Medical Sciences S.r.l.
2.16.1 Nerviano Medical Sciences S.r.l. Details
2.16.2 Nerviano Medical Sciences S.r.l. Major Business
2.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Novartis AG
2.17.1 Novartis AG Details
2.17.2 Novartis AG Major Business
2.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Omeros Corporation
2.18.1 Omeros Corporation Details
2.18.2 Omeros Corporation Major Business
2.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
2.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Gastrointestinal Stromal Tumor (GIST) Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share
3.4.2 Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer Market Share
3.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Gastrointestinal Stromal Tumor (GIST) Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2026)
4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026)
4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026)
4.4 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026)
4.5 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026)
4.6 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Type (2016-2026)
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2016-2026)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Application (2016-2026)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2016-2026)
6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2026)
7.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2026)
7.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
7.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2026)
8.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2026)
8.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
8.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
9.3.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2026)
10.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2026)
10.3 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
10.3.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country
11.3.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Gastrointestinal Stromal Tumor (GIST) Drug Typical Distributors
12.3 Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Ariad Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Ariad Pharmaceuticals, Inc. Major Business
Table 5. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 6. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Arog Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Arog Pharmaceuticals, Inc. Major Business
Table 9. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 10. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Array BioPharma Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Array BioPharma Inc. Major Business
Table 13. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 14. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Astex Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Astex Pharmaceuticals, Inc. Major Business
Table 17. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 18. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Blueprint Medicines Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Blueprint Medicines Corporation Major Business
Table 21. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 22. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Boston Biomedical, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Boston Biomedical, Inc. Major Business
Table 25. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 26. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Calithera Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Calithera Biosciences, Inc. Major Business
Table 29. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 30. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Chipscreen Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Chipscreen Biosciences Ltd Major Business
Table 33. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 34. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Deciphera Pharmaceuticals, LLC Basic Information, Manufacturing Base and Competitors
Table 36. Deciphera Pharmaceuticals, LLC Major Business
Table 37. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 38. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. F. Hoffmann-La Roche Ltd. Major Business
Table 41. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 42. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Horizon Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 44. Horizon Pharma Plc Major Business
Table 45. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 46. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Immunicum AB Basic Information, Manufacturing Base and Competitors
Table 48. Immunicum AB Major Business
Table 49. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 50. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 52. Jiangsu Hengrui Medicine Co., Ltd. Major Business
Table 53. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 54. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Kolltan Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Kolltan Pharmaceuticals, Inc. Major Business
Table 57. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 58. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Natco Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 60. Natco Pharma Limited Major Business
Table 61. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 62. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Nerviano Medical Sciences S.r.l. Basic Information, Manufacturing Base and Competitors
Table 64. Nerviano Medical Sciences S.r.l. Major Business
Table 65. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 66. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 68. Novartis AG Major Business
Table 69. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 70. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Omeros Corporation Basic Information, Manufacturing Base and Competitors
Table 72. Omeros Corporation Major Business
Table 73. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product and Services
Table 74. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 76. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Gastrointestinal Stromal Tumor (GIST) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 79. Head Office and Gastrointestinal Stromal Tumor (GIST) Drug Production Site of Key Manufacturer
Table 80. Gastrointestinal Stromal Tumor (GIST) Drug New Entrant and Capacity Expansion Plans
Table 81. Gastrointestinal Stromal Tumor (GIST) Drug Mergers & Acquisitions in the Past Five Years
Table 82. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2016-2021e) & (K Pcs)
Table 83. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026) & (K Pcs)
Table 84. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 87. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 88. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 91. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2021-2026) & (USD/Pcs)
Table 92. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 93. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 94. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 97. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2021-2026) & (USD/Pcs)
Table 98. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021e) & (K Pcs)
Table 99. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (K Pcs)
Table 100. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 103. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 104. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 105. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 106. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021e) & (K Pcs)
Table 107. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (K Pcs)
Table 108. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 111. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 112. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 113. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 114. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2016-2021e) & (K Pcs)
Table 115. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021-2026) & (K Pcs)
Table 116. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 119. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 120. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 121. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 122. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021e) & (K Pcs)
Table 123. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (K Pcs)
Table 124. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 127. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 128. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 129. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 130. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2016-2021e) & (K Pcs)
Table 131. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2021-2026) & (K Pcs)
Table 132. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2016-2021e) & (K Pcs)
Table 135. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2021-2026) & (K Pcs)
Table 136. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2016-2021e) & (K Pcs)
Table 137. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2021-2026) & (K Pcs)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Gastrointestinal Stromal Tumor (GIST) Drug Typical Distributors
Table 141. Gastrointestinal Stromal Tumor (GIST) Drug Typical Customers
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Picture
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2020
Figure 3. Amcasertib
Figure 4. Anagrelide hydrochloride CR
Figure 5. APG-1351
Figure 6. Binimetinib
Figure 7. Others
Figure 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2020
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (2016-2026) & (K Pcs)
Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
Figure 19. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
Figure 20. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
